The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1197-1203 , December 2009

Dispensing of fluticasone propionate/salmeterol combination in the summer and asthma-related outcomes in the fall

  • Joseph Spahn, MD

      Affiliations

    • National Jewish Health, Denver, Colo
    • Corresponding Author InformationReprint requests: Joseph Spahn, MD, Ira J. and Jacqueline Neimark Laboratory of Clinical Pharmacology in Pediatrics, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206.
    • ,
  • Ketan Sheth, MD, MBA

      Affiliations

    • Lafayette Allergy and Asthma Clinic, Lafayette, Ind
    • ,
  • Wei-Shi Yeh, MS

      Affiliations

    • University of North Carolina, Chapel Hill, NC
    • ,
  • David A. Stempel, MD

      Affiliations

    • GlaxoSmithKline, Research Triangle Park, NC
    • ,
  • Richard H. Stanford, PharmD, MS

      Affiliations

    • GlaxoSmithKline, Research Triangle Park, NC

Received 25 August 2008 ,Revised 9 July 2009 ,Accepted 6 August 2009.

  • Image Result

    Seasonal asthma–related ED visits and hospitalizations throughout the observation period.

    Seasonal asthma–related ED visits and hospitalizations throughout the observation period.

  • Image Result

    Percent of patients with an asthma-related ED visit in the fall for patients with FSC dispensed in the summer and those not dispensed FSC. Yellow lines represent baseline (summer) rate.

    Percent of patients with an asthma-related ED visit in the fall for patients with FSC dispensed in the summer and those not dispensed FSC. Yellow lines represent baseline (summer) rate.

  • Image Result

    Percent of patients with an asthma-related hospitalization in the fall for patients dispensed and not dispensed FSC in the summer. Yellow lines represent baseline (summer) rate.

    Percent of patients with an asthma-related hospitalization in the fall for patients dispensed and not dispensed FSC in the summer. Yellow lines represent baseline (summer) rate.

 Supported by GlaxoSmithKline, Research Triangle Park, NC.

 Disclosure of potential conflict of interest: R. H. Stanford and D. A. Stempel are employees of GlaxoSmithKline. J. Spahn has received honoraria and served as a consultant for GlaxoSmithKline, has received research support from Merck, and has served as an expert witness for GlaxoSmithKline. K. Sheth has received honoraria from Alcon, AstraZeneca, and Sanofi; has served as a consultant for Sepracor (Altana); and has received honoraria and served as a consultant for GlaxoSmithKline. W.-S. Yeh has received consulting fees from GlaxoSmithKline.

PII: S0091-6749(09)01325-6

doi: 10.1016/j.jaci.2009.08.042

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1197-1203 , December 2009

Article Tools

* Image Usage & Resolution